The SCCS Polypill Pilot Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 303 participants.
Also called NCT02278471
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 303 participants
- Sponsor
- Registry
-
NCT02278471
-
- Other papers using this trial's data
- Polypill for Cardiovascular Disease Prevention in an Underserved Population
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02278471. Randomized; no masking; primary purpose prevention. Start 2015-12 (actual); primary completion 2018-06-27 (actual). Results posted on 2019-10-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The SCCS Polypill Pilot Trial
- Condition
- Hypertension
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)
- Lead sponsor
- Vanderbilt University
Record details
- Record id
cardio:ct-nct02278471- Content hash
9160c89a8d4cd5b1f79745ce554c1de5abf2ee39068d45c1e9eb6c2f1310c4a7